Position in VCYT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$710,867
+$490,229 QoQ
Shares Held
12,104
+76.7% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#195
of 367 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Atom Investors LP holds $5,388,940 across 6 Diagnostics & Research names. VCYT ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
11,084 | $1,662,932 | |
| 2 | RVTY |
Revvity, Inc.
|
11,804 | $1,313,313 | |
| 3 | WGS |
GeneDx Holdings Corp.
|
10,697 | $734,349 | |
| 4 | VCYT |
Veracyte, Inc.
This page
|
12,104 | $710,867 | |
| 5 | PSNL |
Personalis, Inc.
|
40,763 | $546,224 | |
| 6 | FLGT |
Fulgent Genetics, Inc.
|
20,529 | $421,255 |
All Filings in VCYT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $710,867 | 12,104 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $220,638 | 6,850 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $323,285 | 7,679 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $263,620 | 7,679 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $379,582 | 14,043 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $1,136,519 | 51,287 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,314,950 | 47,799 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,419,049 | 63,549 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,187,258 | 46,614 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $994,200 | 44,583 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $300,891 | 18,126 | Shares | Sole | 2022-11-08 | |
| 2020-03-31 | $1,930,116 | 79,396 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||